Loading company…
Myocor developed the Coapsys System, a device for treating mitral insufficiency.
Myocor developed the Coapsys System for treating mitral insufficiency by modifying heart geometry. Founded in 1996, the company was based in Maple Grove, US. It raised a total of USD 24.00 mn, including a Series D round led by Prism Venture Management, which closed on October 31, 2008. Edwards Lifesciences Corporation acquired Myocor in October 2008.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in